Category: Zacks Small Cap Research
By Lisa Thompson NYSE:MHH READ THE FULL MHH RESEARCH REPORT Both of Mastech’s (NYSE:MHH) business segments showed growth sequentially and year over year. It reached record quarterly revenues of $54 million and the company expects a strong second half ...
By Tim Moore, CFA NASDAQ:SYTA READ THE FULL SYTA RESEARCH REPORT Initiating Coverage We initiate coverage of Siyata Mobile Inc. (NASDAQ:SYTA) with a valuation price target of $16 per share. Siyata Mobile is a developer and provider of cellular commun ...
By David Bautz, PhD NASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update Presentations at ECCMID Highlight New Data for DLA Agents On July 19, 2021, ContraFect (NASDAQ:CFRX) announced multiple data presentations at the 31st European Congres ...
By John Vandermosten, CFA EPA:ALQGC READ THE FULL ALQGC.PA RESEARCH REPORT REFRESH First Patient Enrolled Quantum (EPA:ALQGC) announced on July 8, 2021 that the first patient had been enrolled in its pivotal Phase III REFRESH trial of once-daily firi ...
By Lisa Thompson OTC:PKKFF READ THE FULL PKKFF RESEARCH REPORT On Tuesday, Peak Fintech (OTC:PKKFF) management release revenue, net income and EBITDA guidance for 2021, 2022 and 2023 as follows: Its previous guidance from last year was $50 million i ...
By Steven Ralston, CFA OTC:TGMGF | ASX:TGM READ THE FULL TGMGF RESEARCH REPORT Theta Gold Mines (OTC:TGMGF) (ASX:TGM) is a junior mining company on the verge of transitioning from a junior exploration company to a gold producer. By targeting high-gra ...
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Revenue Opportunities On July 12, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced the closure of three new employer client contracts derived from wayForward relationship. Averag ...
By David Bautz, PhD NASDAQ:OPNT READ THE FULL OPNT RESEARCH REPORT Business Update Positive Results for OPNT003 PK Study On July 6, 2021, Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) announced positive topline results from the confirmatory pharmacokine ...
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) has been active since our first quarter update published several weeks ago. We saw a $23 million capital raise, the allowance of new pa ...
By M. Marin NYSE:TRC READ THE FULL TRC RESEARCH REPORT Tejon Ranch Company (NYSE:TRC) announced yesterday it has started construction of an industrial building at the Tejon Ranch Commercial Center (TRCC) that is planned to be roughly 630,000-square-f ...